Comparison of Early Retreatment with the Standard Regimen in Verteporfin Therapy of Neovascular Age-Related Macular Degeneration

This publication has 13 references indexed in Scilit:

• Verteporfin Therapy of Subfoveal Minimally Classic Choroidal Neovascularization in Age-Related Macular Degeneration
  Archives of Ophthalmology (1950), 2005
• Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium–Derived Factor
  Investigative Opthalmology & Visual Science, 2003
• Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1
  American Journal of Ophthalmology, 2003
• Sequence of Early Vascular Events after Photodynamic Therapy
  Investigative Opthalmology & Visual Science, 2003
• Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes
  Albrecht von Graefes Archiv für Ophthalmologie, 2002
• Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2
  American Journal of Ophthalmology, 2001
• Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin
  Archives of Ophthalmology (1950), 1999
• Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration
  Archives of Ophthalmology (1950), 1999
• The Prevalence of Age-related Maculopathy in the Rotterdam Study
  Published by Elsevier ,1995
• Prevalence of Age-related Maculopathy
  Ophthalmology, 1992